Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Assessment of agroforestry residue potentials for the bioeconomy in the European Union.

Thorenz A, Wietschel L, Stindt D, Tuma A.

J Clean Prod. 2018 Mar 1;176:348-359. doi: 10.1016/j.jclepro.2017.12.143.

2.

[Recognition and communication of early preventive services in obstetrics : A qualitative interview study with parents].

Prüßmann C, Stindt D, Brunke J, Klinkhammer U, Thyen U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Oct;59(10):1292-9. doi: 10.1007/s00103-016-2420-x. German.

PMID:
27590247
3.

Chemotherapy-Induced mucositis.

Stindt D, Brown MJ.

Adv NPs PAs. 2013 Jun;4(6):27-8. Review. No abstract available.

PMID:
23795414
4.

Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.

Borden LS Jr, Clark PE, Lovato J, Hall MC, Stindt D, Harmon M, M Mohler R, Torti FM.

Cancer. 2006 Sep 1;107(5):1093-100.

5.

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.

Clark PE, Hall MC, Borden LS Jr, Miller AA, Hu JJ, Lee WR, Stindt D, D'Agostino R Jr, Lovato J, Harmon M, Torti FM.

Urology. 2006 Jun;67(6):1257-61.

PMID:
16765186
6.

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.

Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680-5.

7.

Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM.

Urology. 2004 Jun;63(6):1061-5.

PMID:
15183950
8.

Response of hormone refractory prostate cancer to lycopene.

Matlaga BR, Hall MC, Stindt D, Torti FM.

J Urol. 2001 Aug;166(2):613. No abstract available.

PMID:
11458084
9.

[Mucocele formation as a late complication following trauma in the paranasal sinuses area].

Akuamoa-Boateng E, Machtens E, Stindt D.

Fortschr Kiefer Gesichtschir. 1991;36:181-3. German. No abstract available.

PMID:
1869172
10.

An overview of Gly-Oxide liquid in control and prevention of dental disease.

Stindt DJ, Quenette L.

Compendium. 1989 Sep;10(9):514-9.

PMID:
2637067
11.

[The treatment of late damage following burns of the head, neck and face].

Akuamoa-Boateng E, Stindt D, Machtens E, Bonorden SW.

Fortschr Kiefer Gesichtschir. 1989;34:80-4. German. No abstract available.

PMID:
2731890
12.

[Extreme cases of occlusive cysts secondary to antral surgery].

Radtke J, Stindt D, Heuser L.

Dtsch Zahnarztl Z. 1988 Dec;43(12):1350-3. German. No abstract available.

PMID:
3253093
13.

[Chondroplast--a heterologous tissue. Experiences with its use as a supporting material in the visceral cranium].

Zahn W, Stindt D.

Dtsch Z Mund Kiefer Gesichtschir. 1988 Jul-Aug;12(4):333-5. German. No abstract available.

PMID:
3240616
14.

Effect of taste on acceptance of topical fluorides.

Stindt D.

Quintessence Int Dent Dig. 1983 Dec;14(12):1273-6. No abstract available.

PMID:
6585858
15.

Assessing expanded functions performed by hygienists in Missouri.

Minervini R, Harrington M, Stindt D.

Dent Hyg (Chic). 1981 May;55(5):36-41. No abstract available.

PMID:
6945251

Supplemental Content

Loading ...
Support Center